These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 22283852)

  • 1. Extensive accumulation of eosinophil extracellular traps in bullous delayed-pressure urticaria: a pathophysiological link?
    Kerstan A; Simon HU; Yousefi S; Leverkus M
    Br J Dermatol; 2012 May; 166(5):1151-2. PubMed ID: 22283852
    [No Abstract]   [Full Text] [Related]  

  • 2. Bullous delayed pressure urticaria: pathogenic role for eosinophilic granulocytes?
    Kerstan A; Rose C; Simon D; Simon HU; Bröcker EB; Trautmann A; Leverkus M
    Br J Dermatol; 2005 Aug; 153(2):435-9. PubMed ID: 16086763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in disease.
    Yousefi S; Simon D; Simon HU
    Curr Opin Immunol; 2012 Dec; 24(6):736-9. PubMed ID: 22981682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent urticaria--urticarial reaction caused by late phase reaction?
    Kitao A; Nobuhara S; Kore-Eda S; Takahashi K; Nishigori C; Miyachi Y
    Eur J Dermatol; 2001; 11(5):440-2. PubMed ID: 11525952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of tissue factor by eosinophils in patients with chronic urticaria.
    Cugno M; Marzano AV; Tedeschi A; Fanoni D; Venegoni L; Asero R
    Int Arch Allergy Immunol; 2009; 148(2):170-4. PubMed ID: 18802362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels and skin-eosinophil-expression of vascular endothelial growth factor in patients with chronic urticaria.
    Tedeschi A; Asero R; Marzano AV; Lorini M; Fanoni D; Berti E; Cugno M
    Allergy; 2009 Nov; 64(11):1616-22. PubMed ID: 19485983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bullous delayed pressure urticaria; pressure testing may produce a systemic reaction.
    Mijailović BB; Karadaglić DM; Ninković MP; Mladenović TM; Zecević RD; Pavlović MD
    Br J Dermatol; 1997 Mar; 136(3):434-6. PubMed ID: 9115934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophil infiltration, gastric juice and serum eosinophil cationic protein levels in Helicobacter pylori-associated chronic gastritis and gastric ulcer.
    Aydemir SA; Tekin IO; Numanoglu G; Borazan A; Ustundag Y
    Mediators Inflamm; 2004 Dec; 13(5-6):369-72. PubMed ID: 15770055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil cationic protein in patients with fascioliasis: its probable effects on symptoms and signs.
    Demirci M; Kaya S; Cetin ES; Aridogan BC; Korkmaz M
    Scand J Infect Dis; 2006; 38(5):346-9. PubMed ID: 16709536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A histological study of the evolution of solar urticaria.
    Norris PG; Murphy GM; Hawk JL; Winkelmann RK
    Arch Dermatol; 1988 Jan; 124(1):80-3. PubMed ID: 3337546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urticaria in a 68-year-old man.
    Anderson MH; Wray BB; Hooks VH
    Ann Allergy; 1991 Mar; 66(3):207-11. PubMed ID: 2006770
    [No Abstract]   [Full Text] [Related]  

  • 12. Eosinophils and urticaria.
    Staumont-Sallé D; Dombrowicz D; Capron M; Delaporte E
    Clin Rev Allergy Immunol; 2006 Feb; 30(1):13-8. PubMed ID: 16461990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation].
    Ohbayashi H
    Arerugi; 2005 Jan; 54(1):24-35. PubMed ID: 15841673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma.
    Busse WW; Katial R; Gossage D; Sari S; Wang B; Kolbeck R; Coyle AJ; Koike M; Spitalny GL; Kiener PA; Geba GP; Molfino NA
    J Allergy Clin Immunol; 2010 Jun; 125(6):1237-1244.e2. PubMed ID: 20513521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sputum eosinophil markers in monitoring asthmatic patients in United Arab Emirates.
    Almosawi TA; Al-Zubaidy TS; Howorth PH
    Saudi Med J; 2008 Jul; 29(7):1061-4. PubMed ID: 18626546
    [No Abstract]   [Full Text] [Related]  

  • 16. A (G->C) transversion in the 3' UTR of the human ECP (eosinophil cationic protein) gene correlates to the cellular content of ECP.
    Jönsson UB; Byström J; Stålenheim G; Venge P
    J Leukoc Biol; 2006 Apr; 79(4):846-51. PubMed ID: 16434694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
    Xu J; Jiang F; Nayeri F; Zetterström O
    Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histologic studies in "physical urticaria" of the skin. I. The cellular reaction and its course in pressure urticaria].
    Illig L; Engelhardt A; Thielemann K
    Hautarzt; 1970 Aug; 21(8):355-69. PubMed ID: 5518370
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed pressure urticaria syndrome: a clinical expression of interleukin 1.
    Shelley WB; Shelley ED
    Acta Derm Venereol; 1987; 67(5):438-41. PubMed ID: 2448997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophil cationic protein (ECP) is processed during secretion.
    Woschnagg C; Rubin J; Venge P
    J Immunol; 2009 Sep; 183(6):3949-54. PubMed ID: 19692640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.